Document Type
Article
Publication Date
8-8-2016
Abstract
Hypoxia is a universal driver of aggressive tumor behavior, but the underlying mechanisms are not completely understood. Using a phosphoproteomics screen, we now show that active Akt accumulates in the mitochondria during hypoxia and phosphorylates pyruvate dehydrogenase kinase 1 (PDK1) on Thr346 to inactivate the pyruvate dehydrogenase complex. In turn, this pathway switches tumor metabolism toward glycolysis, antagonizes apoptosis and autophagy, dampens oxidative stress, and maintains tumor cell proliferation in the face of severe hypoxia. Mitochondrial Akt-PDK1 signaling correlates with unfavorable prognostic markers and shorter survival in glioma patients and may provide an "actionable" therapeutic target in cancer.
Recommended Citation
Chae, Young Chan; Vaira, Valentina; Caino, M. Cecilia; Tang, Hsin-Yao; Seo, Jae Ho; Kossenkov, Andrew V.; Ottobrini, Luisa; Martelli, Cristina; Lucignani, Giovanni; Bertolini, Irene; Locatelli, Marco; Bryant, Kelly G.; Ghosh, Jagadish C.; Lisanti, Sofia; Ku, Bonsu; Bosari, Silvano; Languino, Lucia R.; Speicher, David W.; and Altieri, Dario C., "Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming." (2016). Department of Cancer Biology Faculty Papers. Paper 127.
https://jdc.jefferson.edu/cbfp/127
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
PubMed ID
27505672
Language
English
Comments
This article has been peer reviewed. It is the authors' final version prior to publication in Cancer Cell, Volume 30, Issue 2, August 2016, Pages 257-272.
The published version is available at https://doi.org/10.1016/j.ccell.2016.07.004. Copyright © Elsevier